Researchers at Western University's Schulich School of Medicine & Dentistry received more than $1.5 million in August 2026 from the Canada Foundation for Innovation. The funding introduces Southwestern Ontario's only high-tech 4D imaging system, supercharging preclinical studies in organoid research, cancer biology, and precision medicine.
This financial backing arrives via the John R. Evans Leaders Fund, a core stream designed to supply up to 40 per cent of necessary laboratory infrastructure costs. By equipping institutions with cutting-edge hardware, the program enables universities to attract and retain top researchers. At Western, the investment targets eight distinct projects addressing critical health, environmental, and economic demands.
Transforming Preclinical Research With 4D Organoid Technology
Van Lu, a member of the physiology and pharmacology department at Schulich Medicine & Dentistry, secured more than $322,000 of the total award for the new 4D imaging system. Working alongside fellow professors Dean Betts and Dr. Julio Martinez-Trujillo, Lu engineered a collaborative framework to make the technology available across disciplines. Organoids—simplified, three-dimensional cellular models measuring about one millimetre across—replicate the structural and functional complexity of human organs.
Using these lab-grown models instead of animal subjects improves the likelihood of successful treatments that can be moved into clinical trials. According to Van Lu, investigators can generate diverse organoids from a single human tissue sample to evaluate multiple pharmaceutical compounds simultaneously. This strategy aligns directly with the goals of precision medicine, identifying patient-specific treatment responses before clinical administration. Lu's specific program focuses on gastrointestinal tract development, shedding light on pathologies such as colon cancer and inflammatory bowel disease.
Other investigators are applying the technology to distinct physiological systems. Dean Betts investigates stem cell-derived embryo models to refine in vitro fertilization outcomes. Meanwhile, Dr. Julio Martinez-Trujillo examines how brain stem cells form the earliest stages of neural connections inside brain organoids, advancing the study of neurodevelopmental diseases.
In Plain English: The Clinical Takeaway
- What are organoids? They are miniature, lab-grown 3D tissue models that mimic real human organs, allowing researchers to study disease mechanisms outside of a living body.
- Why does 4D imaging matter? Traditional microscopes capture static snapshots. This new system records living cells in motion over weeks or months, observing how they develop and react to experimental therapies in real time.
- Impact on patient care: By testing drugs on patient-derived organoids rather than animal models, clinicians can better predict individualized drug responses and accelerate targeted therapies.
Overcoming Static Limitations Through Continuous Observation
Previous methodologies relied heavily on static, three-dimensional snapshots, which provide only a single moment in a cellular lifecycle. The new platform integrates an environmental incubator with a high-tech microscope and camera array, enabling continuous observation of hundreds of organoids simultaneously. Because these biological models require weeks or months to mature, long-term 3D tracking is vital for capturing dynamic changes.
The system records cellular migration, proliferation rates, and morphological shifts triggered by pharmacological interventions. By monitoring how cells communicate and respond to microenvironmental pressures, teams can map disease initiation and progression with unprecedented clarity.
| Research Focus | Lead Investigator | Clinical Target / Application |
|---|---|---|
| Gastrointestinal Tract | Van Lu | Colon cancer, inflammatory bowel disease, nutrient sensing |
| Reproductive Health | Dean Betts | In vitro fertilization optimization, stem cell-derived embryo models |
| Neuroscience | Dr. Julio Martinez-Trujillo | Neural connections, neurodevelopmental diseases |
Funding Transparency and Institutional Impact
The financial infrastructure supporting this technological acquisition stems from federal investments administered by the Canada Foundation for Innovation through the John R. Evans Leaders Fund. By sharing acquisition costs with the university, the federal funding model ensures regional academic health centers maintain globally competitive research environments. The integration of this 4D imaging setup positions Western University as a hub for organoid innovation, drawing cross-disciplinary talent to Southwestern Ontario.
